Sylvie Alonso’s Group
@salonsogroup
Viral host-pathogen interactions and developing subunit vaccines and antivirals are what we love. Led by @NUSMedAlonsoS. Tweets by lab members!
ID: 1651435785097465857
27-04-2023 03:59:22
51 Tweet
114 Takipçi
89 Takip Edilen
Featuring the boss Sylvie Alonso presenting a translational and exciting story about the lab's cDC1 targeting vaccine research at the annual SgSI symposium. 🎉🎉🎉
2 presentations in a month, this time round at #IVBDC23. Sylvie Alonso presenting the recent work on DENV NS1 done by Dr Fakhri :)
so nice to see you again Christopher Ang!!!! till the next conference :)
Featuring our new publication on Molecular Therapy Family of Journals deeply characterizing a cDC1 targeting vaxx strategy we have focused on for years, this time in SARS-CoV-2 context. Overall, our findings present its promise as a next gen pandemic response vaxx strategy Congrats to Nicholas Cheang agn!
📢Don't miss our BDI seminar this Fri 17 May, 12-1pm! 𝗦𝗽𝗲𝗮𝗸𝗲𝗿: A/Prof Sylvie Alonso Sylvie Alonso’s Group @nusingapore 𝗧𝗼𝗽𝗶𝗰: A versatile & powerful dendritic cell-targeting platform to deliver vaccine antigen candidates against infectious diseases bit.ly/3uCUMgc
Delighted to celebrate our latest publication with A/Prof Sylvie Alonso Sylvie Alonso’s Group on dendritic cell-targeting of SARS-CoV-2 antigens for durable and protective immunity. A fantastic collaboration between Monash Biomedicine Discovery Institute and NUS. doi.org/10.1016/j.ymth…
1/ Increasing vaccine protection against #COVID. A/Prof Sylvie Alonso’s Group NUS & A/Prof Mireille Monash Biomedicine Discovery Institute have discovered a technique for prolonging immune response to #SARSCoV2 virus in pre-clinical models using an antibody construct. More: bit.ly/3yKN3Ek
it’s Sylvie Alonso birthday 🎉🎉confetti for the aesthetic shot but note to self, don’t do it on a carpeted floor!